Tenzing Acquisition Corp. Uncategorized Contracts & Agreements

Description of Securities (Filed With SEC on March 30, 2023)

Description of Securities (Filed With SEC on March 22, 2021)

Letter Agreement, dated as of December 14, 2020, by and between the Company, Maxim Group LLC and Maxim Partners LLC (Filed With SEC on December 18, 2020)

Form of Assumed Option (Filed With SEC on December 18, 2020)

Letter Agreement, dated as of March 15, 2016, by and between Marc Cantillon, MD and Reviva Pharmaceuticals, Inc (Filed With SEC on December 18, 2020)

Letter Agreement, dated as of October 28, 2015, by and between Marc Cantillon, MD and Reviva Pharmaceuticals, Inc (Filed With SEC on December 18, 2020)

Form of Backstop Agreement, by and among Tenzing Acquisition Corp., Reviva Pharmaceuticals, Inc., and the Investor named therein (Filed With SEC on October 22, 2020)

Lock-Up Agreement, dated as of July 20, 2020 by and among Dr. Bhat, Tenzing and the Purchaser Representative (Filed With SEC on July 24, 2020)

Form of Lock-Up Agreement (General) (Filed With SEC on July 24, 2020)

Description of the Registrants securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on May 4, 2020)

Letter Agreement, dated August 20, 2018, by and among the Company, its officers, its directors and the Sponsor (Filed With SEC on August 24, 2018)

Form of Indemnity Agreement (Filed With SEC on August 6, 2018)

Form of Letter Agreement among the Registrant and each of the sponsor, directors and officers of the Registrant (Filed With SEC on August 6, 2018)

Specimen Ordinary Shares Certificate (Filed With SEC on August 6, 2018)

Specimen Unit Certificate (Filed With SEC on August 6, 2018)